NVMI · Nova Ltd. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on NVMI. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About NVMI · Nova Ltd.
Nova Ltd. engages in the design, development, production, and sale of process control systems used in the manufacture of semiconductors in Taiwan, the United States, China, Korea, and internationally. The company's product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, such as lithography, Etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. It serves various sectors of the integrated circuit manufacturing industry, including logic, foundry, memory, and packaging sectors, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel.
Live Quote
BUY (score +7) · 12-1 mom 99.8% · RSI 49.2 · above_both · -12.8% from high
Targets blend Wall Street consensus (8 analysts: low $494.00 / mean $597.63 / high $640.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Premium valuation (38x Fwd P/E) with zero insider buying and weak options flow provides no asymmetric edge; anti-signal flags for customer concentration and dilution further cap the upside, making a publishable thesis untenable at this score.
Premium valuation (38x Fwd P/E) with zero insider buying and weak options flow provides no asymmetric edge; anti-signal flags for customer concentration and dilution further cap the upside, making a publishable thesis untenable at this score.
Nova reported record Q1 2026 results on May 14 beating estimates on revenue and EPS with $235.3M in revenue (+10% YoY) and non-GAAP EPS of $2.33 (beat by +6.15%). The company guided Q2 above consensus at $245-255M revenue midpoint vs ~$241M expected, supporting continued momentum. Three directors filed Form 4s on May 20 reporting identical transactions: code 'S' (sale) of 426 shares each at $514.49 — these are RSU vest-and-sell events, not open-market purchases, so the investigation trigger's premise is technically unmet. The stock ran to an all-time high of ~$556 intraday on May 14 before pulling back ~13% and now sits near the 50 DMA with neutral RSI at 47.6.